Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.34 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | G6PC1 | P35575 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14830810 | 0.77 | DAO (0.41) | DAOGSK3BF2ALDH1A1KDM4E | |
| SCHEMBL14830960 | 0.71 | CYP3A4 (0.45) | ALDH1A1SMN1; SMN2RAB9ATSHRNPC1 | |
| SCHEMBL5132433 | 0.68 | ALDH1A1 (0.48) | ALDH1A1GAASMN1; SMN2RAB9AHTT | |
| SCHEMBL10187754 | 0.64 | KMT2A (0.37) | GSK3BALDH1A1RAB9AKMT2AMAPK1 | |
| SCHEMBL6830344 | 0.63 | HTT (0.49) | DAOALDH1A1GAASMN1; SMN2RAB9A | |
| SCHEMBL4994295 | 0.62 | TRPM8 (0.40) | ALDH1A1KDM4EGAARAB9AHTT | |
| SCHEMBL9985198 | 0.62 | HCAR2 (0.36) | ALDH1A1MAPT | |
| SCHEMBL27591751 | 0.62 | F2 (0.34) | DAOGSK3BF2ALDH1A1KDM4E | |
| SCHEMBL2560759 | 0.62 | GSK3B (0.63) | DAOGSK3BF2ALDH1A1KDM4E | |
| SCHEMBL15397598 | 0.61 | LMNA (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2760845-A1 | HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | Amgen Inc. (US) | 2014-08-06 | — | — | EP | disclosed |
| WO-2013049250-A1 | HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER | AMGEN INC. (US) | 2013-04-04 | — | — | WO | disclosed |